Omkar Pharmachem Ltd. benchmarking: Performance to industry peers

Financial

	Omkar Pharmachem	Venmax Drugs&Pharma	Sandu Pharmaceutical
Operational Metrics
Financials
5 yr Average ROE	2.2 %	1.17 %	3.72 %
5yr average Equity Multiplier	1.05	0.08	1.33
5yr Average Asset Turnover Ratio	0.05	0.14	1.23
5yr Avg Net Profit Margin	44.95 %	-19.62 %	2.27 %
Price to Book	3.15	3.29	0.79
P/E	350.0	35.24	21.16
5yr Avg Cash Conversion Cycle	49.27 Days	288.55 Days	48.49 Days
Inventory Days	0.0	5.2 Days	74.6 Days
Days Receivable	49.27 Days	430.69 Days	26.14 Days
Days Payable	0.0	141.12 Days	72.73 Days
5yr Average Interest Coverage Ratio	7.4	-260.56	28.2
5yr Avg ROCE	2.6 %	-47.43 %	5.33 %
5yr Avg Operating Profit Margin	44.39 %	-65.91 %	3.77 %
5 yr average Debt to Equity	0.06	-0.45	0.0
5yr CAGR Net Profit	-1.89 %	-42.57 %	0.39 %
5yr Average Return on Assets	2.09 %	199.45 %	2.79 %
Shareholdings
Promoter Holding	0.03 %	15.14 %	37.79 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-7.99 %	-12.64 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0